Menu

Researchers Mine Centipede Toxins for Analgesics

Venomous centipedes may harbor a clue to the creation of a successful pain-killing compound for humans.

Jan 1, 2018
Catherine Offord

ELVIND UNDHEIM

Centipede venom has a long history as a painkiller—toxins from the Chinese red-headed centipede (Scolopendra subspinipes mutilans) have been used in Chinese medicine for hundreds of years. But the leggy creature’s arsenal has only recently gained attention as inspiration for modern analgesics. “There’s on the order of 3,000 venomous centipedes,” says Glenn King, a biochemist at the University of Queensland, Australia. “Yet they’re massively underexplored in terms of what’s in the venom.”

In 2013, King and colleagues reported that one centipede-made peptide, Ssm6a, selectively inhibits NaV1.7—a voltage-gated sodium channel implicated in pain sensing in mammals, including humans (PNAS, 110:17534-39). In rodent models, Ssm6a was more potent than morphine, though the finding has yet to be reproduced. Last year, a Chinese team showed that another centipede peptide, potassium channel blocker SsmTX-I, has analgesic properties in mice (J Ppt Sci, 23:384-91, 2017).

“These venoms are full of ion-channel modulators,” says King. From a pain-killing perspective, “some of those molecules may turn out to be more or less useful therapeutically—we just don’t know yet.”

Read about other animal groups researchers are exploring for pain-killing leads in the full feature story, “Animal Analgesics.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.